Fujifilm Toyama Chemical Co. Ltd.
Division of Fujifilm Holdings Corp.
fftc.fujifilm.co.jp/en
Latest From Fujifilm Toyama Chemical Co. Ltd.
Asia Deal Watch: Fujifilm Affiliate Out-Licenses Antifungal Candidate To Canada’s Appili
Novel antifungal T-2307, discovered by FUJIFILM Toyama, works by selectively disrupting mitochondrial function. Excelra and Maruho team up to repurpose existing drugs.
Cynata In Potential Japan Double As Fujifilm Acquires Lead Asset
Diversified Japanese giant gains global rights to Cynata’s novel therapy for GvHD as part of continued push into cell and regenerative medicine, amid ongoing discussions between Sumitomo Dainippon and the Australian bioventure over a potential wider acquisition.
Finance Watch: 5AM, Longevity Close Funds, New Incubators Launch To Support Early-Stage Companies
News of 5AM's two latest venture funds follows the launch of Longevity Vision Fund as well as LA BioMed's and RUNLABS’ announcements that they will open new incubators in 2019. Also, Passage Bio launches with $115.5m, but the largest recent VC deal was HaiHe's $146.6m financing.
Asia Deal Watch: ReVance Licenses Chinese Rights To Botox Competitor To Fosun
With Phase III data in 2,800 patients for reducing frown lines, ReVance anticipates filing RT002 for US approval in 2019. ABL licenses two bispecific antibody candidates to TRIGR, while Sun looks to expand in dermatology with Pola buyout.
Company Information
- Industry
- In Vitro Diagnostics
-
Medical Devices
-
Diagnostic Imaging Equipment & Supplies
- Molecular Imaging
-
Diagnostic Imaging Equipment & Supplies
-
Pharmaceuticals
- Radiopharmaceuticals, Contrast Agents
- Therapeutic Areas
- Cancer
- Metabolic Disorders
- Neurology, Nervous System
- Alias(es)
- Toyama Chemical Co. Ltd.
- Fujifilm RI Pharma Co. Ltd.
- Ownership
- Private
- Headquarters
-
Worldwide
-
Asia
-
Pacific Rim
-
Japan
-
Japan
-
Pacific Rim
-
Asia
- Parent & Subsidiaries
- Fujifilm Holdings Corp.
- Senior Management
- Junji Okada, Pres.
- Contact Info
-
Fujifilm Toyama Chemical Co. Ltd.
Phone: (81) 3 5381 3889
14-1, Kyobashi 2-Chome
Chuo-ku
Tokyo ,
Japan
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice